Pharma Journalist -

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Polivy (polatuzumab vedotin-piiq) in…
Read More...

SAE Media Group reports: the Biosensors for Medical Wearables Conference will cover AI technologies and respiratory monitoring  Returning for the 2nd annual year, the Biosensors for…
Read More...

Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announced it has received notice from the U.S.…
Read More...

Mitsubishi Tanabe Pharma America, Inc. announced the publication of a paper entitled, "Intravenous edaravone treatment in ALS and survival: an exploratory, retrospective, administrative…
Read More...

Gilead Sciences, Inc. announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for Trodelvy (sacituzumab govitecan) in Greater…
Read More...

Merck, known as MSD outside the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational class of engineered circular RNA (oRNA)…
Read More...

Catalent, Inc. announced that it has reached an agreement to acquire Metrics Contract Services (Metrics), a full-service specialty Contract Development and Manufacturing Organization…
Read More...

Evotec SE  and Alpine Immune Sciences, Inc. announced that Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc., expanded a multi-year partnership with Alpine for the…
Read More...

aTyr Pharma, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track designation for its lead therapeutic candidate, efzofitimod (ATYR1923),…
Read More...

TRON Group, Inc. and Nanopharmaceutics, Inc. ("Nano"), a privately-held clinical-stage pharmaceutical development company incorporated in Florida, announced today the signing of a…
Read More...